Jefferies Group’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-25,700
Closed -$197K 2949
2019
Q2
$197K Buy
+25,700
New +$138K ﹤0.01% 2142
2019
Q1
Sell
-11,752
Closed -$77K 2557
2018
Q4
$77K Sell
11,752
-2,348
-17% -$26.3K ﹤0.01% 1990
2018
Q3
$243K Buy
+14,100
New +$210K ﹤0.01% 1994
2018
Q1
Sell
-4,556
Closed -$52K 2588
2017
Q4
$52K Buy
4,556
+1,556
+52% +$23.2K ﹤0.01% 2372
2017
Q3
$57K Buy
+3,000
New +$61.8K ﹤0.01% 2205
2017
Q2
Sell
-23,376
Closed -$513K 2473
2017
Q1
$463K Sell
23,376
-19,628
-46% -$438K ﹤0.01% 1629
2016
Q4
$1.04M Buy
43,004
+39,059
+990% +$1.09M 0.01% 1265
2016
Q3
$110K Buy
3,945
+3,849
+4,009% +$102K ﹤0.01% 2027
2016
Q2
$2K Sell
96
-47,327
-100% -$1.34M ﹤0.01% 2088
2016
Q1
$1.59M Buy
+47,423
New +$1.49M 0.01% 950
2015
Q4
Sell
-412
Closed -$13.9K 2494
2015
Q3
$13K Sell
412
-48,747
-99% -$2.38M ﹤0.01% 2172
2015
Q2
$2.38M Buy
+49,159
New +$2.07M 0.01% 830
2015
Q1
Sell
-105,597
Closed -$2.78M 2322
2014
Q4
$2.78M Buy
+105,597
New +$2.32M 0.02% 597

Other funds holding PGEN

Jefferies Group's PGEN Position: Q3 2019 in Review

Jefferies Group sold out of Precigen (PGEN) in Q3 2019, closing a stake of 25,700 shares — an estimated $197K sold.

Jefferies Group first reported a position in PGEN in Q4 2014 and held it in 13 quarters. The position peaked at $2.78M in Q4 2014. 170 funds tracked by Wall St. Rank hold PGEN as of Q3 2019.

  • Jefferies Group reported no remaining Precigen position as of Q3 2019 after selling out during the quarter.
  • Jefferies Group sold 25,700 Precigen shares in Q3 2019, an estimated $197K.
  • Jefferies Group first reported a position in Precigen in Q4 2014 and held it in 13 quarters.
  • Jefferies Group's Precigen position peaked at $2.78M in Q4 2014.
  • 170 funds tracked by Wall St. Rank held Precigen as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.